List of nationally authorised medicinal products

Size: px
Start display at page:

Download "List of nationally authorised medicinal products"

Transcription

1 6 September 2018 EMA/612350/2018 Human Medicines Evaluation Division Active substance: azelastine Procedure no.: PSUSA/ / Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0) Facsimile +44 (0) Send a question via our website An agency of the European Union European Medicines Agency, Reproduction is authorised provided the source is acknowledged.

2 National Number Corifina 0,5 mg/ml, /H/5289/ MEDA PHARMA U. ES colirio en solución Azelastine 0.5 mg / ml, /H/5289/001 PL 15142/0035 MEDA PHARMACEUTICALS UK Eye Drops, solution. LTD LASTICOM 0,5 mg/ml, /H/5289/ MEDA PHARMA GMBH & CO. IT collirio, soluzione Allergodil akut /H/5289/ MEDA PHARMA GMBH & CO. Augentropfen. 0,5 mg/ml, Augentropfen, Lösung. Oculastin 0,5 mg/ml /H/5289/ MEDA AB SE ögondroppar, lösning Oculastin oogdruppels. /H/5289/001 RVG MEDA PHARMA B.V. NL 0,5 mg/ml, oogdruppels, oplossing. Allergodrop 0,5 mg/ml /H/5289/ MEDA PHARMA GMBH AT Augentropfen Azelastine Eye Drops 0.5 /H/5289/001 PA 1332/010/001 MEDA HEALTH SALES IE mg / ml, Eye Drops, solution IRELAND LIMITED Oculastin /H/5289/ MEDA AS DK Afluon 0,15% w/v, ρινικό not available / MEDA PHARMACEUTICALS GR εκνέφωμα, διάλυμα Azelastinhydrochlorid AL not available ALIUD PHARMA GMBH 0,5 mg/ml Augentropfen Azela-Vision MD sine 0,5 SE/H/1183/01/DC OMNIVISION GMBH mg/ml Augentropfen Azela-Vision MD sine 0,5 SE/H/1183/01/DC OMNIVISION GMBH AT mg/ml Augentropfen Azelastine OmniVision, SE/H/1183/01/DC OMNIVISION GMBH SE 0,5 mg/ml ögondroppar, lösning Azelastin COMOD 0,5 mg/ml Augentropfen, Lösung AT/H/0454/ URSAPHARM GES.M.B.H. AT EMA/612350/2018 Page 2/15

3 National Number Azelastin-COMOD, 0,5 mg/ml collyre en solution Azelastin-COMOD, 0,5 mg/ml collyre en solution VISUZEL 0,5 mg/ml collirio, soluzione Azelastin-COMOD 0.5 mg/ml eye drops, solution Azelastin-COMOD, 0,5 mg/ml oogdruppels, oplossing Pollival 0,5 mg/ml Augentropfen, Lösung Azelastin COMOD, 0,5 mg/ml, krople do oczu, roztwór Azelastin COMOD 0,5 mg/ml oční kapky, roztok Azelastin-COMOD, 0,5 mg/ml oogdruppels, oplossing Azelastin POS 1 mg/ml Pollival 1 mg/ml Azelastin-POS 1 mg/ml neusspray, oplossing AZELASTIN-POS 1 mg/ml nosní sprej, roztok Azelastin-POS 1 mg/ml solution pour pulvérisation nasale AT/H/0454/001 BE URSAPHARM BENELUX B.V. BE AT/H/0454/001/DC URSAPHARM BENELUX B.V. LU AT/H/0454/ VISUFARMA SPA IT AT/H/0454/001 MA63/01001 URSAPHARM ARZNEIMITTEL GMBH AT/H/0454/001/DC BE URSAPHARM BENELUX B.V. BE AT/H/0454/001/DC URSAPHARM ARZNEIMITTEL GMBH AT/H/0454/ URSAPHARM POLAND SP. Z. O.O. AT/H/0454/001 64/057/13-C URSAPHARM SPOL. S.R.O. CZ AT/H/0454/001 RVG URSAPHARM BENELUX B.V. NL AT/H/0351/ URSAPHARM GES.M.B.H. AT AT/H/0351/ URSAPHARM ARZNEIMITTEL GMBH AT/H/0351/002 RVG URSAPHARM BENELUX B.V. NL AT/H/0351/002 69/149/15-C URSAPHARM SPOL. S.R.O. CZ AT/H/0351/002 BE URSAPHARM BENELUX B.V. BE MT PL EMA/612350/2018 Page 3/15

4 National Number Azelastin-POS 1 mg/ml AT/H/0351/002 BE URSAPHARM BENELUX B.V. BE neusspray, oplossing Azelastin POS, 1 mg/ml, AT/H/0351/ URSAPHARM POLAND SP. Z. PL aerozol do nosa, roztwór O.O. Azelastin-POS AT/H/0351/002/DC URSAPHARM BENELUX B.V. LU Allergodil 0,1%, not available MEDA PHARMA SIA EE ninasprei Allergodil 1,5 mg/ml not available LT/1/97/0233/002 MEDA PHARMA SIA LT nosies purškalas (tirpalas) Allergodil 1,5 mg/ml not available LT/1/97/0233/006 MEDA PHARMA SIA LT nosies purškalas (tirpalas) Allergodil 1,5 mg/ml not available LT/1/97/0233/005 MEDA PHARMA SIA LT nosies purškalas (tirpalas) Allergodil 1,5 mg/ml not available LT/1/97/0233/004 MEDA PHARMA SIA LT nosies purškalas (tirpalas) Allergodil 1,5 mg/ml not available LT/1/97/0233/003 MEDA PHARMA SIA LT nosies purškalas (tirpalas) Lastin 0,13 mg/dos not available MEDA OY FI nässpray, lösning Lastin 0,13 mg/annos not available MEDA OY FI nenäsumute, liuos ALLERGODIL oční kapky not available 64/210/00-C MEDA PHARMA GMBH & CO. CZ Vividrin akut Azelastin /H/5289/ DR. GERHARD MANN CHEM.- antiallergische Augentropfen PHARM. FABRIK GMBH Allergodil 0,05% acu not available MEDA PHARMA SIA LV pilieni, šķīdums Azelastina MABO 0,5 mg/ml colirio en solución not available MABO-FARMA, ES EMA/612350/2018 Page 4/15

5 National Number Allergodil 0,1% deguna not available MEDA PHARMA SIA LV aerosols Vivispray 1 mg/ml MT/H/0234/001 24/0305/17-S PHARMASWISS ČESKÁ SK nosová roztoková aerodisperzia REPUBLIKA S.R.O. Vivispray 1 mg/ml sprej MT/H/0234/001 HR-H PHARMASWISS ČESKÁ HR za nos, otopina REPUBLIKA S.R.O. Azelastin PharmaSwiss 1 MT/H/0234/ PHARMASWISS ČESKÁ mg/ml Nasenspray, Lösung REPUBLIKA S.R.O. Vivispray 1 mg/ml nasal MT/H/0234/001 MA1011/00401 PHARMASWISS ČESKÁ MT spray, solution REPUBLIKA S.R.O. Rhinolast 1,5 mg/ml /H/5291/ MEDA PHARMA GMBH & CO. Rinelaz 0,19 mg/dos /H/5291/ MEDA AB SE nässpray, lösning Allergodil 1,5 mg/ml /H/5291/001 RVG MEDA PHARMA B.V. NL neusspray, oplossing Rhinolast S 0.15% Nasal /H/5291/001 PL 15142/0235 MEDA PHARMACEUTICALS UK Spray LTD Allergodil mit Sucralose /H/5291/ MEDA PHARMA GMBH AT 1,5 mg/ml Nasenspray Allergodil Forte /H/5291/ MEDA AS DK Rhinolast S 1.5 mg/ml /H/5291/001 PA1332/015/004 MEDA HEALTH SALES IE Nasal Spray, Solution IRELAND LIMITED Afluon sucralosa 1,5 /H/5291/ MEDA PHARMA S.L. ES mg/ml, solución para pulverización nasal Allergodil 1,5 mg /ml, /H/5291/ MEDA PHARMA S.P.A. IT Allergodil 1,5 mg /ml, /H/5291/ MEDA PHARMA S.P.A. IT Allergodil 1,5 mg /ml, /H/5291/ MEDA PHARMA S.P.A. IT EMA/612350/2018 Page 5/15

6 National Number Allergodil 1,5 mg /ml, Allergodil 1,5 mg /ml, Allergodil 0,05 % akių lašai (tirpalas) Allergodil 0,05 % akių lašai (tirpalas) Allergodil, 1,5 mg/ml, ninasprei, lahus Azelastinhydrochlorid Kohne Pharma 0,5 mg/ml Augentropfen Allergodil, 0,05% silmatilgad, lahus Azelastinhydrochlorid Stulln 0,5 mg/ml Augentropfen Allestin, 0,5 mg/ml, krople do oczu, roztwór Алергодил 0,05% капки за очи, разтвор Алергодил 0,1% спрей за нос, разтвор AFLUON 0,05% οφθαλμικές σταγόνες, διάλυμα ALLERGODIL 0,1 % Nasenspray ALLERGODIL 0,05 % Augentropfen ALLERGODIL 0,05 % Augentropfen ALLERGODIL 0,1 % Nasenspray /H/5291/ MEDA PHARMA S.P.A. IT /H/5291/ MEDA PHARMA S.P.A. IT not available LT/1/98/0280/002 MEDA PHARMA SIA LT not available LT/1/98/0280/001 MEDA PHARMA SIA LT not available MEDA PHARMA SIA EE /H/3827/001/DC KOHNE PHARMA GMBH not available MEDA PHARMA SIA EE /H/3389/ PHARMA STULLN GMBH /H/3389/ PHARMA STULLN GMBH PL not available MEDA PHARMA GMBH & CO. not available MEDA PHARMA GMBH & CO. not available 97308/13 MEDA PHARMACEUTICALS not available BE MEDA PHARMA N.V. BE not available BE MEDA PHARMA N.V. BE not available MEDA PHARMA N.V. LU not available MEDA PHARMA N.V. LU BG BG GR EMA/612350/2018 Page 6/15

7 National Number AFLUON 1 mg/ml solución para pulverización nasal Lastin S 1,5 mg/ml nefúði, lausn Astepro 1,5 mg/ml nefúði, lausn Алергодил S 0,15% спрей за нос, разтвор Allergodil 1 mg/ml pršilo za nos, raztopina Allergodil 1MG/ML Solução para Pulverização Nasal Allergodil 1MG/ML Solução para Pulverização Nasal AZEP 1mg/ml solução para pulverização nasal AZEP 1mg/ml solução para pulverização nasal Azelastine neusallergie Meda, neusspray 1 mg/ml Allergodil 0,5 mg/ml kapi za oko, otopina Allergodil oldatos orrspray Allergodil oldatos szemcsepp ALLERGODIL 0,05 % Oogdruppels, oplossing ALLERGODIL 0,05 % collyre en solution. not available MEDA PHARMA S.L. ES not available IS/1/16/041/01 MEDA AB IS not available IS/1/16/042/01 MEDA AB IS not available MEDA PHARMA GMBH & CO. not available H/99/00142/001 MEDA PHARMA GMBH & CO. not available MEDA PHARMA GMBH & CO. not available MEDA PHARMA GMBH & CO. not available MEDA PHARMA PRODUTOS FARMACÊUTICOS, PT not available MEDA PHARMA PRODUTOS PT FARMACÊUTICOS, not available RVG MEDA PHARMA B.V. NL not available HR-H MYLAN HRVATSKA D.O.O. HR not available OGYI-T-4877/01 MYLAN EPD KFT. HU not available OGYI-T-4877/02 MYLAN EPD KFT. HU not available BE MEDA PHARMA N.V. BE not available MEDA PHARMA N.V. LU BG SI PT PT EMA/612350/2018 Page 7/15

8 National Number Allergodil očná instilácia not available 64/0157/99-S MEDA PHARMA GMBH & CO. SK ALLERGODIL 0,05 % not available BE MEDA PHARMA N.V. BE collyre en solution. Allergodil-Filmtabletten not available MEDA PHARMA GMBH AT Allergodil Filmtabletten not available MEDA PHARMA GMBH & CO. 2,2 mg/filmtablette ALLERGODIL, 0,5 mg/ml, not available MEDA PHARMA GMBH & CO. PL krople do oczu, roztwór Allergodil filmom not available 24/0206/97-S MEDA PHARMA GMBH & CO. SK obalené tablety Allergodil-Nasenspray not available MEDA PHARMA GMBH AT Allergodil Nasenspray 1 mg / 1 ml, Nasenspray, Lösung not available MEDA PHARMA GMBH & CO. ALLERGODIL, 1 mg/ml (0,1%), aerozol do nosa, roztwór ALLERGODIL, 0,1 %, spray nasal ALLERGODIL 0,1 % Neusspray not available 7602 MEDA PHARMA GMBH & CO. not available BE MEDA PHARMA N.V. BE not available BE MEDA PHARMA N.V. BE Allergodil not available 24/0205/97-S MEDA PHARMA GMBH & CO. SK ALLERGODIL, 0,1 %, not available MEDA PHARMA N.V. LU spray nasal Allergodil akut Nasenspray 1 mg / 1 ml, not available MEDA PHARMA GMBH & CO. Allergodil akut Duo Augentropfen: 0,5 mg / ml Augentropfen, Lösung Nasenspray: 1 mg / ml not available MEDA PHARMA GMBH & CO. PL EMA/612350/2018 Page 8/15

9 National Number Allergodil Kombipackung Augentropfen: 0,5 mg / ml Augentropfen, Lösung Nasenspray: 1 mg / ml Rhinolast 140 micrograms per Spray, Nasal Spray Vividrin akut Azelastin Kombi-Packung gegen Heuschnupfen Augentropfen: 0,5 mg / ml Augentropfen, Lösung Nasenspray : 1 mg / ml Vividrin akut Azelastin Nasenspray gegen Heuschnupfen 1 mg / 1 ml, AFLUON 0,1% w/v ρινικό εκνέφωμα, διάλυμα LASTIN 0,5 mg/ml øyedråper, oppløsning Lastin 0,13 mg/dose nesespray, oppløsning Lastin 0,13 mg/dos nässpray, lösning Lastin 0,13 mg/úðaskammt, nefúði, lausn Rhinolast Hayfever 140 micrograms per spray, nasal spray solution. not available MEDA PHARMA GMBH & CO. not available PA 1332/15/1 MEDA HEALTH SALES IRELAND LIMITED not available MEDA PHARMA GMBH & CO. not available MEDA PHARMA GMBH & CO. not available 7733/ MEDA PHARMACEUTICALS GR not available MEDA AS NO not available MEDA AS NO not available MEDA AB SE not available MEDA AB IS not available PA1322/015/002 MEDA HEALTH SALES IRELAND LIMITED IE IE EMA/612350/2018 Page 9/15

10 National Number Allespray 1mg/ml Spray not available MEDA PHARMA S.P.A. IT Nasale, Soluzione Allergodil Nevel, not available RVG MEDA PHARMA B.V. NL neusspray, oplossing 1 mg/ml Allergospray-Nasenspray not available MEDA PHARMA GMBH AT Allergodil, næsespray, not available MEDA AS DK opløsning Azelastinhydrochlorid /H/3827/001/DC KOHNE PHARMA GMBH Kohne Pharma 0,5 mg/ml Augentropfen Azelastine hydrochloride /H/3827/ KOHNE PHARMA GMBH PL Kohne 0,5 mg/ml, krople do oczu, roztwór Astepro 0,15% w/v, not available / MEDA PHARMACEUTICALS GR ρινικό εκνέφωμα, διάλυμα Azelastín Xantis 1 mg/ml MT/H/0256/001 24/0364/17-S XANTIS PHARMA LIMITED SK nosová roztoková aerodisperzia Azelastine Xantis 1 MT/H/0256/001 MA1188/00101 XANTIS PHARMA LIMITED MT mg/ml nasal spray solution Azelastin POS 0,5 mg/ml AT/H/0351/ URSAPHARM ARZNEIMITTEL AT Augentropfen, Lösung GMBH Azelastin-POS 0,5 mg/ml AT/H/0351/ URSAPHARM ARZNEIMITTEL Augentropfen, Lösung GMBH Azelamed 0,5 mg/ml /H/3889/001 HR-H MIBE PHARMACEUTICALS HR kapi za oko, otopina D.O.O. Azelamed 1 mg/ml sprej /H/3889/002 HR-H MIBE PHARMACEUTICALS HR za nos, otopina D.O.O. Azedil 0,5 mg/ml /H/3889/001/DC RMAPHARM GMBH AT Augentropfen Azedil 1 mg/ml Nasenspray /H/3889/ RMAPHARM GMBH AT EMA/612350/2018 Page 10/15

11 National Number Azedil 0,5 mg/ml Augentropfen, Lösung Azedil 1 mg/ml Azedil Kombi-Packung mit 0,5 mg/ml Augentropfen, Lösung und 1 mg/ml Azelamed, 0,5 mg/ml, krople do oczu, roztwór Azelamed, 1 mg/ml, aerozol do nosa, roztwór Azelastinhydrochlorid Kohne Pharma 0,5 mg/ml Augentropfen Azelastine Galenicum 1 mg/ml nasal spray, solution Azelastin Galenicum 1 mg/ml Nasenspray, Losung ALLERGODIL 1 mg/ml Nosni sprej, roztok Astepro 1,5 mg/ml Astepro 1.5 mg/ml Nasal Spray, Solution Astepro 1,5 mg/ml, solución para pulverización nasal Astepro 1,5 mg/ml neusspray, oplossing Astepro 0.15% Nasal Spray /H/3889/ RMAPHARM AG /H/3889/ RMAPHARM AG /H/3889/ RMAPHARM AG /H/3889/ SUN-FARM SP. Z.O.O. PL /H/3889/ SUN-FARM SP. Z.O.O. PL /H/3827/001/DC KOHNE PHARMA GMBH MT/H/0235/001 MA255/02001 GALENICUM HEALTH, S.L. MT MT/H/0235/ GALENICUM HEALTH, S.L. not available 24/002/97-C MEDA PHARMA GMBH & CO. CZ /H/5292/ MEDA PHARMA GMBH & CO. /H/5292/001 PA1332/39/2 MEDA HEALTH SALES IE IRELAND LIMITED /H/5292/ MEDA PHARMA U. ES /H/5292/001 RVG MEDA PHARMA B.V. NL /H/5292/001 PL 15142/0236 MEDA PHARMACEUTICALS LTD UK EMA/612350/2018 Page 11/15

12 National Number Astepro næsespray, opløsning Astepro 0,15 % Nasenspray Astepro 0,19 mg/dos nässpray, lösning Astepro 1,5 mg/ml, Astepro 1,5 mg/ml, Astepro 1,5 mg/ml, Astepro 1,5 mg/ml, Astepro 1,5 mg/ml, Azela-Vision sine 0,5 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis Azela-Vision sine 0,5 mg/ml Augentropfen, Lösung im Einzeldosisbehältnis Allergodil 0,5 mg/ml Augentropfen ALLERGODIL 0,5 mg/ml, collirio, soluzione ALLERGODIL 0,5 mg/ml collirio, soluzione Lastin 0,5 mg/ml ögondroppar, lösning Allergodil Augentropfen 0,5 mg/ml, Augentropfen, Lösung /H/5292/ MEDA AS DK /H/5292/ MEDA PHARMA GMBH AT /H/5292/ MEDA AB SE /H/5292/ MEDA PHARMA S.P.A. IT /H/5292/ MEDA PHARMA S.P.A. IT /H/5292/ MEDA PHARMA S.P.A. IT /H/5292/ MEDA PHARMA S.P.A. IT /H/5292/ MEDA PHARMA S.P.A. IT /H/3852/001/DC FORMERLY SE/H/1105/001/DC /H/3852/001/DC FORMERLY SE/H/1105/001/DC OMNIVISION GMBH AT OMNIVISION GMBH /H/5290/ MEDA PHARMA GMBH AT /H/5290/ MEDA PHARMA S.P.A. IT /H/5290/ MEDA PHARMA S.P.A. IT /H/5290/ MEDA OY FI /H/5290/ MEDA PHARMA GMBH & CO. EMA/612350/2018 Page 12/15

13 National Number Allergodil, 0,5 mg/ml, /H/5290/ MEDA PHARMA PRODUTOS PT colírio, solução FARMACÊUTICOS, Allergodil, 0,5 mg/ml, /H/5290/ MEDA PHARMA PRODUTOS PT colírio, solução FARMACÊUTICOS, Allergodil, 0,5 mg/ml, /H/5290/ MEDA PHARMA PRODUTOS PT colírio, solução FARMACÊUTICOS, Afluón 0,5 mg / ml, /H/5290/ MYLAN IRE HEALTHCARE ES colirio en solución LIMITED Optilast. 0.5 mg / ml, /H/5290/001 PL 46302/0136 MYLAN PRODUCTS LIMITED UK Eye Drops, solution Allergodil oogdruppels /H/5290/001 RVG MEDA PHARMA B.V. NL 0,5 mg/ml, oogdruppels, oplossing. Lastin 0,5 mg/ml /H/5290/ MEDA OY FI silmätipat, liuos Lastin 0,5 mg/ml /H/5290/ MEDA AB SE ögondroppar, lösning Optilast. /H/5290/001 PA 1332/009/001 MEDA HEALTH SALES IE 0.5 mg / ml, Eye Drops, solution IRELAND LIMITED Allergodil, øjendråber, /H/5290/ MEDA AS DK opløsning Allergodil 1,5 mg/ml not available MEDA PHARMA SIA LV deguna aerosols, šķīdums ALLERGODIL 0,127 not available MEDA PHARMA SAS FR mg/dose, solution pour pulvérisation nasale Loxin /H/5290/ DR. GERHARD MANN CHEM.- PHARM. FABRIK GMBH ALLERGODIL 0,05 POUR not available MEDA PHARMA SAS FR CENT, collyre en solution ALLERGODIL 0,05 POUR CENT, collyre en solution not available MEDA PHARMA SAS FR EMA/612350/2018 Page 13/15

14 National Number Allergodil 0,1% nosies purškalas (tirpalas) Azelastina MABO 0,5 mg/ml colirio en solución PROALLERGODIL 0,127 mg/dose, solution pour pulvérisation nasale PROALLERGODIL 0,127 mg/dose, solution pour pulvérisation nasale PROALLERGODIL 0,127 mg/dose, solution pour pulvérisation nasale Azelastin Devatis 0,5 mg/ml Augentropfen im Einzeldosisbehältnis Azelastinehydrochloride Devatis 0,5 mg/ml, oogdruppels, oplossing in verpakking voor éénmalig gebruik Tebarat 0,5 mg/ml colirio en solución en envase unidosis Tebarat 0,5 mg/ml colírio, solução em recipiente unidose Tebarat 0,5 mg/ml colírio, solução em recipiente unidose Tebarat 0,5 mg/ml colírio, solução em recipiente unidose not available LT/1/97/0233/001 MEDA PHARMA SIA LT not available MABO-FARMA, ES not available MEDA PHARMA SAS FR not available MEDA PHARMA SAS FR not available MEDA PHARMA SAS FR NL/H/2860/ VATIS GMBH NL/H/2860/001 RVG VATIS GMBH NL ES/H/0178/ LABORATORIOS SALVAT, ES/H/0178/001/DC LABORATORIOS SALVAT, ES/H/0178/ LABORATORIOS SALVAT, ES/H/0178/ LABORATORIOS SALVAT, ES PT PT PT EMA/612350/2018 Page 14/15

15 National Number Tebarat 0,5 mg/ml collirio, soluzione in contenitore monodose Tebarat 0,5 mg/ml collirio, soluzione in contenitore monodose Tebarat 0,5 mg/ml collirio, soluzione in contenitore monodose ES/H/0178/ LABORATORIOS SALVAT, ES/H/0178/ LABORATORIOS SALVAT, ES/H/0178/ LABORATORIOS SALVAT, IT IT IT EMA/612350/2018 Page 15/15

List of nationally authorised medicinal products

List of nationally authorised medicinal products 10 September 2015 EMA/622830/2015 Procedure Management and Committees Support Active substance: azelastine Procedure no.: PSUSA/00000277/201412 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 09 June 2017 EMA/36849/2017 Human Medicines Evaluation Division Active substance(s): brimonidine / timolol Procedure No.: PSUSA/00000431/201609 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 July 2018 EMA/497430/2018 Human Medicines Evaluation Division Active substance: tafluprost / timolol Procedure no.: PSUSA/00010324/201712 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 26 October 2017 EMA/663700/2017 Human Medicines Evaluation Division Active substance: cromoglicic acid Procedure no.: PSUSA/00000883/201702 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 5 May 2017 EMA/288255/2017 Human Medicines Evaluation Division Active substance: pilocarpine (ophthalmic formulation) Procedure no.: PSUSA/00002410/201608 30 Churchill Place Canary Wharf London E14 5EU

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 13 September 2017 EMA/706786/2017 Human Medicines Evaluation Division Active substance: Octenidine dihydrochloride / phenoxyethanol Procedure no.: PSUSA/00002199/201701 30 Churchill Place Canary Wharf

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 8 March 2018 EMA/182668/2018 Human Medicines Evaluation Division Active substance(s): triamcinolone (topical and nasal formulations) Procedure No.: PSUSA/00003017/201707 30 Churchill Place Canary Wharf

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 28 September 2017 EMA/658449/2017 Human Medicines Evaluation Division Active substance: olodaterol Procedure no.: PSUSA/00010245/201703 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 6 September 2018 EMA/615391/2018 Human Medicines Evaluation Division Active substance: tobramycin (nebuliser solution) (apart from centrally authorised product) Procedure no.: PSUSA/00009316/201712 30

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 10 September 2015 EMA/677092/2015 Procedure Management and Committees Support Active substance: glatiramer Procedure no.: PSUSA/00001529/201411 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 1 December 2016 EMA/750653/2016 Human Medicines Evaluation Division Active substance: valganciclovir Procedure no.: PSUSA/00003089/201603 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 20 July 2016 EMA/270645/2015 Procedure Management and Committees Support Active substance: apomorphine Procedure no.: PSUSA/00000227/201511 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 11 October 2017 EMA/784453/2017 Human Medicines Evaluation Division List of nationally authorised medicinal products Active substance(s): ipratropium / salbutamol Procedure No.: PSUSA/00001781/201701 30

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 28 September 2017 EMA/639167/2017 Human Medicines Evaluation Division Active substance: zanamivir Procedure no.: PSUSA/00003141/201701 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 1 September 2017 EMA/580096/2017 Human Medicines Evaluation Division Active substance: terbutaline Procedure no.: PSUSA/00002897/201612 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 10 September 2015 EMA/612853/2015 Procedure Management and Committees Support Active substance: tobramycin (nebuliser solution) Procedure no.: PSUSA/00009316/201412 30 Churchill Place Canary Wharf London

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/817337/2017 Human Medicines Evaluation Division Active substance: Itraconazole Procedure no.: PSUSA/00001798/201703 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/812360/2017 Human Medicines Evaluation Division Active substance(s): mupirocin Procedure No.: PSUSA/00002096/201703 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 11 September 2017 EMA/604559/2017 Human Medicines Evaluation Division Active substance: iron / parenteral preparations Procedure no.: PSUSA/00010236/201701 30 Churchill Place Canary Wharf London E14 5EU

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 6 September 2018 EMA/608492/2018 Human Medicines Evaluation Division Active substance: betahistine Procedure no.: PSUSA/00000389/201712 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 January 2017 EMA/36356/2017 Human Medicines Evaluation Division Active substance: hydroxyzine chloride / hydroxyzine pamoate and all fixed combination, hydroxyzine Procedure no.: PSUSA/00001696/201605

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 April 2018 EMA/231137/2018 Human Medicines Evaluation Division Active substance: fluvoxamine Procedure no.: PSUSA/00001458/201707 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 01 December 2016 Human Medicines Evaluation Division Active substance: Procedure no.: PSUSA/00002591/201604 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 29 September 2017 EMA/658556/2017 Procedure Management and Committees Support Active substance: loratadine Procedure no.: PSU/00001907/201702 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/795271/2017 Human Medicines Evaluation Division Active substance: vinorelbine Procedure no.: PSUSA/00003124/201704 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 06 July 2017 EMA/436040/2017 Human Medicines Evaluation Division Active substance: Procedure no.: PSUSA/00001815/201610 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 27 October 2016 EMA/719205/2016 Human Medicines Evaluation Division Active substance: ethinylestradiol / gestodene (except for transdermal application) Procedure no.: PSUSA/00001308/201603 30 Churchill

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 26 October 2017 EMA/690754/2017 Human Medicines Evaluation Division Active substance: fish oil / olive oil / soybean oil / triglycerides mediumchain Procedure no.: PSUSA/00010223/201702 30 Churchill Place

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 17 May 2018 EMA/303456/2018 Human Medicines Evaluation Division Active substance: bromazepam Procedure no.: PSUSA/00000435/201708 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 21 June 2017 EMA/610895/2017 Human Medicines Evaluation Division Active substance: felbamate Procedure no.: PSUSA/00010155/201609 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 08 March 2018 EMA/170163/2018 Human Medicines Evaluation Division Active substance: enalapril / hydrochlorothiazide Procedure no.: PSUSA/00001212/201707 30 Churchill Place Canary Wharf London E14 5EU United

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 29 November 2018 EMA/880324/2018 Human Medicines Evaluation Division Active substance: enalapril Procedure no.: PSUSA/00001211/201803 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 14 April 2016 EMA/284169/2016 Procedure Management and Committees Support Active substance: influenza vaccine (split virion, inactivated) (non centrally products) Procedure no.: PSUSA/00010298/201508 30

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 11 January 2018 EMA/24585/2018 Human Medicines Evaluation Division Active substance: esomeprazole / naproxen Procedure no.: PSUSA/00001270/201704 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 5 November 2015 EMA/230130/2016 Procedure Management and Committees Support Active substance: cabergoline Procedure no.: PSUSA/00000477/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 April 2018 EMA/243033/2018 Human Medicines Evaluation Division Active substance: fenofibrate Procedure no.: PSUSA/00001362/201707 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 1 September 2017 EMA/593212/2017 Human Medicines Evaluation Division List of nationally authorised medicinal products Active substance(s): flurbiprofen Procedure No.: PSUSA/00001450/201611 30 Churchill

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 11 October 2017 EMA/691535/2017 Human Medicines Evaluation Division Active substance: Haemophilus type b conjugate vaccines Procedure no.: PSUSA/00001584/201702 30 Churchill Place Canary Wharf London E14

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 11 February 2016 EMA/255959/2016 Procedure Management and Committees Support Active substance: calcitonin salmon, synthetic analogue of eel calcitonin Procedure No.: PSUSA/00000494/201506 30 Churchill

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 April 2018 EMA/227889/2018 Human Medicines Evaluation Division Active substance(s): typhoid polysaccharide vaccine Procedure No.: PSUSA/00003065/201708 30 Churchill Place Canary Wharf London E14 5EU

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/817351/2017 Human Medicines Evaluation Division Active substance: Lidocaine / prilocaine (not centrally authorised product) Procedure no.: PSUSA/00001867/201703 30 Churchill Place

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 April 2018 EMA/382206/2018 Human Medicines Evaluation Division Active substance(s): naproxen Procedure No.: PSUSA/00002125/201708 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 July 2018 EMA/462856/2018 Human Medicines Evaluation Division Active substance: econazole, econazole nitrate / triamcinolone acetonide, econazole nitrate / zinc oxide Procedure no.: PSUSA/00001195/201711

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 3 December 2015 EMA/98477/2016 Procedure Management and Committees Support Active substance: acarbose Procedure no.: PSUSA/00000017/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 8 March 2018 EMA/182904/2018 Human Medicines Evaluation Division Active substance(s): fluticasone propionate / formoterol fumarate dihydrate Procedure No.: PSUSA/00010339/201707 30 Churchill Place Canary

More information

Package leaflet: Information for the user. LUXFEN, <[2 mg/ml eye drops, solution]> Active substance: brimonidine tartrate

Package leaflet: Information for the user. LUXFEN, <[2 mg/ml eye drops, solution]> Active substance: brimonidine tartrate Package leaflet: Information for the user LUXFEN, Active substance: brimonidine tartrate Read all of this leaflet carefully before you start using this medicine because

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 7 July 2016 EMA/437334/2016 Procedure Management and Committees Support Division Active substance: Terazosin Procedure no.: PSUSA/00002895/201511 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 12 April 2018 EMA/223740/2018 Human Medicines Evaluation Division Active substance: fludarabine Procedure no.: PSUSA/00001406/201708 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 6 September 2018 EMA/619619/2018 Human Medicines Evaluation Division Active substance: haemophilus influenzae / klebsiella ozaenae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 21 February 2018 EMA/208334/2018 Human Medicines Evaluation Division Active substance: ibuprofen / pseudoephedrine Procedure no.: PSUSA/00001711/201707 30 Churchill Place Canary Wharf London E14 5EU United

More information

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride Package leaflet: Information for the user Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. NALOXONE 400 microgram/ml solution for injection or infusion. naloxone hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. NALOXONE 400 microgram/ml solution for injection or infusion. naloxone hydrochloride PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER NALOXONE 400 microgram/ml solution for injection or infusion naloxone hydrochloride Read all of this leaflet carefully before you start using

More information

Implementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO

Implementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO Implementation Report on the patient safety Recommendation 2009/C 151/01 Healthcare Systems Unit DG SANCO Published 15 November 2012 REPORT FROM THE COMMISSION TO THE COUNCIL on the basis of Member States'

More information

Fluticasone propionate 50 micrograms/actuation, nasal spray, suspension

Fluticasone propionate 50 micrograms/actuation, nasal spray, suspension Package leaflet: Information for the user Fluticasone propionate 50 micrograms/actuation, nasal spray, suspension Fluticasone Propionate Read all of this leaflet carefully before you start using this medicine

More information

Package leaflet: Information for the user. Naloxone 400 microgram/ml solution for injection or infusion naloxone hydrochloride

Package leaflet: Information for the user. Naloxone 400 microgram/ml solution for injection or infusion naloxone hydrochloride Package leaflet: Information for the user Naloxone 400 microgram/ml solution for injection or infusion naloxone hydrochloride Read all of this leaflet carefully before you start using this medicine because

More information

Package leaflet: Information for the user. Fluticasone propionate 50 micrograms/actuation nasal spray, suspension. Fluticasone Propionate

Package leaflet: Information for the user. Fluticasone propionate 50 micrograms/actuation nasal spray, suspension. Fluticasone Propionate Package leaflet: Information for the user Fluticasone propionate 50 micrograms/actuation nasal spray, suspension Fluticasone Propionate Read all of this leaflet carefully before you start using this medicine

More information

Please note that this draft Annex I will be updated to amend information on concerned products/mahs

Please note that this draft Annex I will be updated to amend information on concerned products/mahs 22 March 2018 EMA/197481/2018 Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of, applicants, marketing authorisation holders in the member states for for omega-3

More information

European Union herbal monograph on Pistacia lentiscus L., resin (mastix)

European Union herbal monograph on Pistacia lentiscus L., resin (mastix) 7 July 2015 EMA/HMPC/46758/2015 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Pistacia lentiscus L., resin (mastix) Draft Discussion in Working Party on European Union

More information

(Invented) Name Strength Pharmaceutical Form. 3 mg/3 ml Solution for injection. Kytril 2 mg - Filmtabletten 2 mg Film-coated tablet Oral use

(Invented) Name Strength Pharmaceutical Form. 3 mg/3 ml Solution for injection. Kytril 2 mg - Filmtabletten 2 mg Film-coated tablet Oral use ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1 Austria Austria Bulgaria Bulgaria

More information

Ensuring protection of public health and patients in member states: priorities, constraints, opportunities

Ensuring protection of public health and patients in member states: priorities, constraints, opportunities Ensuring protection of public health and patients in member states: priorities, constraints, opportunities Dr. Christa Wirthumer-Hoche AGES Austrian Medicines and Medical Devices Agency Vienna, Austria

More information

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective Prof. Ing. Juraj Nemec, CSc. Masaryk University, Czech Republic, Size of government

More information

European Union herbal monograph on Eschscholzia californica Cham., herba

European Union herbal monograph on Eschscholzia californica Cham., herba 28 January 2015 EMA/HMPC/680372/2013 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Eschscholzia californica Cham., herba Final Discussion in Working Party on European

More information

EUROPEAN MEDICINES AGENCY DECISION. of 20 July 2008

EUROPEAN MEDICINES AGENCY DECISION. of 20 July 2008 European Medicines Agency Doc. Ref. EMEA/357907/2008 P/53/2008 EUROPEAN MEDICINES AGENCY DECISION of 20 July 2008 on the application for agreement of a Paediatric Investigation Plan for Atorvastatin calcium

More information

CONSULTATION DOCUMENT: ARM 90 OTRIVINE EXTRA DUAL RELIEF NASAL SPRAY SOLUTION

CONSULTATION DOCUMENT: ARM 90 OTRIVINE EXTRA DUAL RELIEF NASAL SPRAY SOLUTION MHRA 151 Buckingham Palace Road Victoria London SW1W 9SZ United Kingdom Telephone +44 (0)20 3080 6039 Email Abiodun.aderogba@mhra.gsi.gov.uk mhra.gov.uk 25 February 2015 Dear Sir/Madam CONSULTATION DOCUMENT:

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Lidocaine Accord 10 mg/ml solution for injection Lidocaine Accord 20 mg/ml solution for injection Lidocaine hydrochloride Read all of this leaflet carefully before

More information

Trends in injecting drug use in Europe

Trends in injecting drug use in Europe Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information

More information

Annex I. Article 107i of Directive 2001/83/EC. Procedure number: EMEA/H/A-107i/ March 2013 EMA/147828/2013 Patient Health Protection

Annex I. Article 107i of Directive 2001/83/EC. Procedure number: EMEA/H/A-107i/ March 2013 EMA/147828/2013 Patient Health Protection 07 March 2013 EMA/147828/2013 Patient Health Protection Annex I List of the names, pharmaceutical s, strengths of the medicinal products, routes of, marketing authorisation holders in the member states

More information

European Union herbal monograph on Peumus boldus Molina, folium

European Union herbal monograph on Peumus boldus Molina, folium 22 November 2016 EMA/HMPC/453725/2016 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Peumus boldus Molina, folium Final Initial assessment Discussion in Working Party

More information

LIMITE EN COUNCIL OF THE EUROPEAN UNION. Brussels, 7 July /11 LIMITE ENFOPOL 228 DAPIX 81

LIMITE EN COUNCIL OF THE EUROPEAN UNION. Brussels, 7 July /11 LIMITE ENFOPOL 228 DAPIX 81 COUNCIL OF THE EUROPEAN UNION Brussels, 7 July 2011 12390/11 LIMITE ENFOPOL 228 DAPIX 81 NOTE From: Presidency To: Law Enforcement Working Party No. prev. doc.: CM 1508/11 Subject: Results of the questionnaire

More information

European Union herbal monograph on Symphytum officinale L., radix

European Union herbal monograph on Symphytum officinale L., radix 5 May 2015 EMA/HMPC/572846/2009 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Symphytum officinale L., radix Final Discussion in Working Party on Community monographs

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 30 November 2017 EMA/806830/2017 Human Medicines Evaluation Division Active substance: piroxicam Procedure no.: PSUSA/00002438/201704 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone

More information

European Union herbal monograph on Glycine max (L.) Merr., lecithinum

European Union herbal monograph on Glycine max (L.) Merr., lecithinum 31 January 2017 EMA/HMPC/220599/2016 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Glycine max (L.) Merr., lecithinum Final Discussion in Working Party on European Union

More information

European Union herbal monograph on Ruscus aculeatus L. rhizoma

European Union herbal monograph on Ruscus aculeatus L. rhizoma 30 January 2018 EMA/188804/2017 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Ruscus aculeatus L. rhizoma Draft Initial assessment Discussion in Working Party on European

More information

European Union herbal monograph on Pelargonium sidoides DC and/or Pelargonium reniforme Curt., radix

European Union herbal monograph on Pelargonium sidoides DC and/or Pelargonium reniforme Curt., radix 05 June 2018 EMA/HMPC/444244/2015 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Pelargonium sidoides DC and/or Pelargonium Final Initial assessment Discussion in Working

More information

Package leaflet: Information for the user. Rhesonativ 625 IU/ml, solution for injection Human anti-d immunoglobulin

Package leaflet: Information for the user. Rhesonativ 625 IU/ml, solution for injection Human anti-d immunoglobulin Package leaflet: Information for the user Human anti-d immunoglobulin Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this

More information

European Union herbal monograph on Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba

European Union herbal monograph on Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba 24 November 2015 EMA/HMPC/712511/2014 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba Final Discussion

More information

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11

More information

Package leaflet: Information for the user. Nasofan TM Aqueous 50 microgram Nasal Spray Suspension Fluticasone Propionate

Package leaflet: Information for the user. Nasofan TM Aqueous 50 microgram Nasal Spray Suspension Fluticasone Propionate Package leaflet: Information for the user Nasofan TM Aqueous 50 microgram Nasal Spray Suspension Fluticasone Propionate Read all of this leaflet carefully before you start using this medicine because it

More information

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11

More information

European Medicines Agency decision

European Medicines Agency decision EMA/497687/2017 European Medicines Agency decision P/0245/2017 of 4 September 2017 on the refusal of a paediatric investigation plan and on the refusal of a deferral and on the granting of a waiver for

More information

'SECTION B EU PARTY. The following abbreviations are used:

'SECTION B EU PARTY. The following abbreviations are used: 'SECTION B EU PARTY The following abbreviations are used: AT Austria BE Belgium BG Bulgaria CY Cyprus CZ Czech Republic DE Germany DK Denmark ES Spain EE Estonia EU European Union, including all its Member

More information

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State) DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) DECENTRALISED PROCEDURE FINAL PUBLICLY AVAILABLE ASSESSMENT REPORT

More information

European Union herbal monograph on Oenothera biennis L. or Oenothera lamarckiana L., oleum

European Union herbal monograph on Oenothera biennis L. or Oenothera lamarckiana L., oleum 5 June 2018 EMA/HMPC/753041/2017 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Oenothera biennis L. or Oenothera lamarckiana L., oleum Final Discussion in Working Party

More information

Pharmaceutical Pricing & Reimbursement Information. PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH

Pharmaceutical Pricing & Reimbursement Information. PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH PPRI - Comparative Analysis PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH PPRI Conference Vienna, 29 June 2007 PPRI Conference, Vienna, 29 June 2007 1 Comparative Analysis - Outline

More information

EUROPEAN CITIZENS DIGITAL HEALTH LITERACY

EUROPEAN CITIZENS DIGITAL HEALTH LITERACY Flash Eurobarometer 404 EUROPEAN CITIZENS DIGITAL HEALTH LITERACY SUMMARY Fieldwork: September 2014 Publication: November 2014 This survey has been requested by the European Commission, Directorate-General

More information

European Union herbal monograph on Agrimonia eupatoria L., herba

European Union herbal monograph on Agrimonia eupatoria L., herba 28 January 2015 EMA/HMPC/680597/2013 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Agrimonia eupatoria L., herba Final Discussion in Working Party on European Union monographs

More information

Initial (Full) Marketing Authorisation application accelerated assessment timetables

Initial (Full) Marketing Authorisation application accelerated assessment timetables 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European

More information

European Union herbal monograph on Helichrysum arenarium (L.) Moench, flos

European Union herbal monograph on Helichrysum arenarium (L.) Moench, flos 29 September 2015 EMA/HMPC/41108/2015 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Helichrysum arenarium (L.) Moench, flos Draft Discussion in Working Party on European

More information

European Medicines Agency decision

European Medicines Agency decision EMA/757980/2016 European Medicines Agency decision P/0313/2016 of 21 December 2016 on the agreement of a paediatric investigation plan for complex of povidone and iodine / dexamethasone (SHP640) (EMEA-001936-PIP01-16)

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 28 September EMA/662335/2017 Human Medicines Evaluation Division List of nationally authorised medicinal products Active substance(s): levosalbutamol, salbutamol Procedure No.: PSUSA/00010330/201701 30

More information

European Union herbal monograph on Echinacea pallida (Nutt.) Nutt., radix

European Union herbal monograph on Echinacea pallida (Nutt.) Nutt., radix 05 June 2018 EMA/HMPC/737380/2018 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Echinacea pallida (Nutt.) Nutt., radix Final Initial assessment Discussion in Working

More information

European Medicines Agency decision

European Medicines Agency decision EMA/131632/2016 European Medicines Agency decision P/0082/2016 of 18 March 2016 on the agreement of a paediatric investigation plan and on the granting of a waiver for tetracaine (hydrochloride) / oxymetazoline

More information

VARIATIONS : IMPACT ON ADMINISTRATIVE BURDEN AND FEES. Rose-Marie Molina EMA Infoday London, 14th March 2014

VARIATIONS : IMPACT ON ADMINISTRATIVE BURDEN AND FEES. Rose-Marie Molina EMA Infoday London, 14th March 2014 Rose-Marie Molina EMA Infoday London, 14th March 2014 Before 1234/2008 Regulation, variation procedures in the European Union for industry was synonymous of: - Lack of visibility about timelines - Lack

More information

September 2014 January 2015 March 2015 May 2015 Adoption by Committee on Herbal Medicinal Products (HMPC) for release for consultation

September 2014 January 2015 March 2015 May 2015 Adoption by Committee on Herbal Medicinal Products (HMPC) for release for consultation 7 July 2015 EMA/HMPC/39453/2015 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Sideritis scardica Griseb.; Sideritis clandestina (Bory & Chaub.) Hayek; Sideritis Draft

More information

European Union herbal monograph on Hedera helix L., folium

European Union herbal monograph on Hedera helix L., folium 21 November 2017 EMA/HMPC/325716/2017 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Hedera helix L., folium Final Initial assessment Discussion in Working Party on European

More information

European Union herbal monograph on Curcuma longa L. (C. domestica Valeton), rhizoma

European Union herbal monograph on Curcuma longa L. (C. domestica Valeton), rhizoma 21 November 2017 EMA/HMPC/329755/2017 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Curcuma longa L. (C. domestica Valeton), Draft Initial assessment Discussion in Working

More information

European Union herbal monograph on Melilotus officinalis (L.) Lam., herba

European Union herbal monograph on Melilotus officinalis (L.) Lam., herba 28 March 2017 EMA/HMPC/44166/2016 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Melilotus officinalis (L.) Lam., herba Draft Initial assessment Discussion in Working

More information

European Union herbal monograph on Hedera helix L., folium

European Union herbal monograph on Hedera helix L., folium 24 November 2015 EMA/HMPC/586888/2014 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Hedera helix L., folium Final Initial assessment Discussion in Working Party on European

More information

Module Page 1 of 1

Module Page 1 of 1 Bupivacaine solution for Injection 2.5 mg / ml and 5 mg / ml 1.3 Product information 1.3.1 SPC, labelling and package leaflet 1.3.1.1 Package leaflet Enclosed in subsequent pages, Module 1.3.1 Page 1 of

More information

Draft. Jul 2015 (MLWP) Discussion in Working Party on European Union monographs and list

Draft. Jul 2015 (MLWP) Discussion in Working Party on European Union monographs and list 27 March 2018 EMA/HMPC/432278/2015 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Fragaria vesca L., Fragaria moschata Weston, Fragaria viridis Weston and Fragaria x ananassa

More information